Bonny Parkinson : Citation Profile

Macquarie University

3

H index

1

i10 index

39

Citations

RESEARCH PRODUCTION:

18

Articles

2

Papers

RESEARCH ACTIVITY:

   14 years (2011 - 2025). See details.
   Cites by year: 2
   Journals where Bonny Parkinson has often published
   Relations with other researchers
   Recent citing documents: 11.    Total self citations: 1 (2.5 %)

MORE DETAILS IN:
ABOUT THIS REPORT:

   Permalink: http://citec.repec.org/ppa1146
   Updated: 2026-05-02    RAS profile: 2026-02-16    
   Missing citations? Add them    Incorrect content? Let us know

Relations with other researchers

Works with:

Gu, Yuanyuan (3)

Authors registered in RePEc who have co-authored more than one work in the last five years with Bonny Parkinson.

Is cited by:

Lancsar, Emily (3)

Petrie, Dennis (2)

Gu, Yuanyuan (1)

Brazier, John (1)

EPSTEIN, DAVID (1)

Vass, Caroline (1)

Chen, Gang (1)

van Exel, Job (1)

Gyrd-Hansen, Dorte (1)

Sculpher, Mark (1)

Haywood, Philip (1)

Cites to:

Hall, Jane (3)

Gray, Alastair (3)

Mortimer, Duncan (3)

Conti, Gabriella (3)

Jones, Andrew (3)

Froud, Robert (3)

Athey, Susan (3)

Imbens, Guido (3)

Hernandez Alava, Monica (2)

Brazier, John (2)

Viney, Rosalie (2)

Main data

Where Bonny Parkinson has published?

Journals with more than one article published# docs
PharmacoEconomics8
Applied Health Economics and Health Policy4
The European Journal of Health Economics2

Working Papers Series with more than one paper published# docs
Working Papers / CHERE, University of Technology, Sydney2

Recent works citing Bonny Parkinson (2025 and 2024)

YearTitle of citing document
2025Long-term public healthcare burden associated with intimate partner violence among Canadian women: A cohort study. (2025). O'Campo, Patricia ; Essue, Beverley M ; Dusing, Gabriel John ; Metheny, Nicholas. In: Health Policy. RePEc:eee:hepoli:v:155:y:2025:i:c:s0168851025000387.

Full description at Econpapers || Download paper

2026An inventory of policy levers to reduce low value care: Results of a rapid scoping review. (2026). Tjosvold, Lisa ; Warkentin, Lindsey M ; Bond, Ken. In: Health Policy. RePEc:eee:hepoli:v:164:y:2026:i:c:s0168851025002623.

Full description at Econpapers || Download paper

2025Male social embeddedness and intimate partner violence perpetration in Tanzania. (2025). Mshana, Gerry ; Brambilla, Rebecca ; Stckl, Heidi ; Malibwa, Donati ; Mosha, Neema. In: Social Science & Medicine. RePEc:eee:socmed:v:365:y:2025:i:c:s0277953624010062.

Full description at Econpapers || Download paper

2025The experience of intimate partner violence and age at the onset of multimorbidity: a population-based cohort study in Australian women. (2025). Baneshi, Mohammad R ; Dobson, Annette ; Mishra, Gita D. In: Social Science & Medicine. RePEc:eee:socmed:v:381:y:2025:i:c:s0277953625006252.

Full description at Econpapers || Download paper

2025The Impact of Intimate Partner Violence on Healthcare Utilization: Evidence From Vietnam. (2025). Le, Duc Dung ; Giang, Long Thanh. In: Review of Economics of the Household. RePEc:kap:reveho:v:23:y:2025:i:2:d:10.1007_s11150-024-09751-4.

Full description at Econpapers || Download paper

2026Deriving Health Utility Values Using Mapping Methods Among the Chinese Population: A Systematic Review. (2026). Hong, Tianqi ; Xie, Shitong ; Wu, Jing ; Geng, Jialu ; Fang, Haoran ; Luo, Chang. In: Applied Health Economics and Health Policy. RePEc:spr:aphecp:v:24:y:2026:i:1:d:10.1007_s40258-025-00992-7.

Full description at Econpapers || Download paper

2024Mapping from SIBDQ to EQ-5D-5L for patients with inflammatory bowel disease. (2024). Stargardt, Tom ; Bokemeyer, Bernd ; Steiner, Isa Maria. In: The European Journal of Health Economics. RePEc:spr:eujhec:v:25:y:2024:i:3:d:10.1007_s10198-023-01603-9.

Full description at Econpapers || Download paper

2026Predicting EQ-5D-3L utility values from clinical data in a prospective cohort of kidney transplant recipients. (2026). Foucher, Y ; Bonnemains, V ; Dantan, E ; Giral, M ; David, C ; Tessier, P. In: The European Journal of Health Economics. RePEc:spr:eujhec:v:27:y:2026:i:1:d:10.1007_s10198-025-01802-6.

Full description at Econpapers || Download paper

2025Cost-minimization analysis of postoperative antibiotic use in high horseshoe anal fistula: evidence from a randomized controlled trial in China. (2025). Zhi, Congcong ; Li, Chen ; Wei, Zijian ; Cheng, Yicheng ; Yuan, YE ; Xu, Pengyi ; Zheng, Lihua. In: Health Economics Review. RePEc:spr:hecrev:v:15:y:2025:i:1:d:10.1186_s13561-025-00697-6.

Full description at Econpapers || Download paper

2025Cost Comparisons in NICE Technology Appraisals: An External Assessment Group Perspective. (2025). Ramos, Isaac Corro ; Yang, Huiqin ; Armstrong, Nigel ; Patel, Mubarak ; Poley, Marten J ; Al, Maiwenn J ; Stirk, Lisa. In: PharmacoEconomics. RePEc:spr:pharme:v:43:y:2025:i:10:d:10.1007_s40273-025-01522-y.

Full description at Econpapers || Download paper

2026Comment on “Cost Comparisons in NICE Technology Appraisals: An External Assessment Group Perspective” by Marten J. Poley et al.. (2026). Lovell, Alan ; Abdelsabour, Ahmed ; Melendez-Torres, G J ; Lee, Dawn ; Allen, Alexander. In: PharmacoEconomics. RePEc:spr:pharme:v:44:y:2026:i:1:d:10.1007_s40273-025-01551-7.

Full description at Econpapers || Download paper

Works by Bonny Parkinson:

YearTitleTypeCited
2022Lifetime health costs of intimate partner violence: A prospective longitudinal cohort study with linked data for out-of-hospital and pharmaceutical costs In: Economic Modelling.
[Full Text][Citation analysis]		article5
2011Considering consumer choice in the economic evaluation of mandatory health programmes: A review In: Health Policy.
[Full Text][Citation analysis]		article1
2012Measuring the loss of consumer choice in mandatory health programs using Discrete Choice Experiments. CHERE Working Paper 2012/04 In: Working Papers.
[Citation analysis]		paper0
2013Pharmaceutical policy in Australia. CHERE Working Paper 2013/01 In: Working Papers.
[Full Text][Citation analysis]		paper0
2011Integrating Health Economics Into the Product Development Cycle In: Medical Decision Making.
[Full Text][Citation analysis]		article5
2013Measuring the Loss of Consumer Choice in Mandatory Health Programmes Using Discrete Choice Experiments In: Applied Health Economics and Health Policy.
[Full Text][Citation analysis]		article2
2018The Real-World Cost-Effectiveness of Coronary Artery Bypass Surgery Versus Stenting in High-Risk Patients: Propensity Score-Matched Analysis of a Single-Centre Experience In: Applied Health Economics and Health Policy.
[Full Text][Citation analysis]		article0
2019Economic Evaluations of Childhood Hearing Loss Screening Programmes: A Systematic Review and Critique In: Applied Health Economics and Health Policy.
[Full Text][Citation analysis]		article0
2019Correction to: Economic Evaluations of Childhood Hearing Loss Screening Programmes: A Systematic Review and Critique.(2019) In: Applied Health Economics and Health Policy.
[Full Text][Citation analysis]
This paper has nother version. Agregated cites: 0		article
2014Economic evaluations of trastuzumab in HER2-positive metastatic breast cancer: a systematic review and critique In: The European Journal of Health Economics.
[Full Text][Citation analysis]		article2
2022The cost-effectiveness of unilateral cochlear implants in UK adults In: The European Journal of Health Economics.
[Full Text][Citation analysis]		article0
2015Disinvestment and Value-Based Purchasing Strategies for Pharmaceuticals: An International Review In: PharmacoEconomics.
[Full Text][Citation analysis]		article16
2016Real-World Evidence: A Comparison of the Australian Herceptin Program and Clinical Trials of Trastuzumab for HER2-Positive Metastatic Breast Cancer In: PharmacoEconomics.
[Full Text][Citation analysis]		article1
2016Authors’ Reply to Palozzo and Messori: ‘‘Disinvestment and Value-Based Purchasing Strategies for Pharmaceuticals: An International Review’’ In: PharmacoEconomics.
[Full Text][Citation analysis]		article0
2019Is Reclassification of the Oral Contraceptive Pill from Prescription to Pharmacist-Only Cost Effective? Application of an Economic Evaluation Approach to Regulatory Decisions In: PharmacoEconomics.
[Full Text][Citation analysis]		article1
2022Cost-Effectiveness Analysis of Prostate-Specific Membrane Antigen (PSMA) Positron Emission Tomography/Computed Tomography (PET/CT) for the Primary Staging of Prostate Cancer in Australia In: PharmacoEconomics.
[Full Text][Citation analysis]		article0
2023Mapping the Patient-Reported Outcomes Measurement Information System (PROMIS-29) to EQ-5D-5L In: PharmacoEconomics.
[Full Text][Citation analysis]		article1
2024Bring Out Your Dead: A Review of the Cost Minimisation Approach in Health Technology Assessment Submissions to the Australian Pharmaceutical Benefits Advisory Committee In: PharmacoEconomics.
[Full Text][Citation analysis]		article3
2025Unravelling the Association Between Uncertainties in Model-based Economic Analysis and Funding Recommendations of Medicines in Australia In: PharmacoEconomics.
[Full Text][Citation analysis]		article0
2022An examination of machine learning to map non‐preference based patient reported outcome measures to health state utility values In: Health Economics.
[Full Text][Citation analysis]		article2

CitEc is a RePEc service, providing citation data for Economics since 2001. Last updated March, 14 2026. Contact: CitEc Team